ARCHIVES

Aromasin Approved By FDA For ER+ Early Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 10 | October 28, 2005

Download PDF Visit The Full Archive

Related Articles

Radiotherapy Provides Longer Life To Brain Cancer Patients

May 28, 2010

Critics of FDA misunderstand Bayesian analysis, statisticians say.

August 5, 2005

In Brief: U – South Western Wins BMS Grant; ONS Gets $1.6 M; Unilever Chair In Diet Formed At CINJ

May 7, 1999

A Special Report: Language With A Purpose–von Eschenbach’s Four Years at NCI.

May 19, 2006

Raloxifene Protects Women At High or Low Risk of Disease

September 29, 2006

Arimidex Gets Full Approval For HR+ Early Breast Cancer

September 30, 2005